Bio-rad outlines updated 2025 guidance amid academic and macro challenges
Source: SeekingAlpha
2025-05-01 22:35:55 ET
More on Bio-Rad Labs, Bio-Rad Laboratories, Inc., etc.
- Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript
- Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript
- Bio-Rad Labs Non-GAAP EPS of $2.54 beats by $0.76, revenue of $585.4M beats by $12.17M
- Bio-Rad Labs Q1 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Bio-Rad Labs
Read the full article on Seeking Alpha
For further details see:
Bio-rad outlines updated 2025 guidance amid academic and macro challenges
Bio-Rad Laboratories Inc. Class A
NASDAQ: BIO
BIO Trading
11.5% G/L:
$277.42 Last:
471,754 Volume:
$274.72 Open:
BIO Latest News
BIO Stock Data
$8,088,674,023
21,121,296
0.01%
179
N/A
Biotechnology & Life Sciences
Healthcare
US
Hercules
